Skip to content
The Nexus
DossierENTITY

US Health and Human Services

Coverage of US Health and Human Services in the Nexus archive.

Earliest in view: May 5 · 13:12 UTCMost recent: Jun 30 · 07:15 UTC
Co-mentioned in this coverage
Recent coverage
  • HEALTHJun 30 · 07:15 UTCOHIO CAPITAL JOURNAL
    Federal health agency cancels most of its teen pregnancy prevention grants

    The U.S. Health and Human Services agency canceled 53 out of 67 grants totaling $68 million under the Teen Pregnancy Prevention Program, citing misalignment with agency priorities. Grantees included universities, health departments, and Planned Parenthood affiliates in multiple states, with one organization, AccessMatters, stating the termination would devastate youth access to reproductive health programs.

  • HEALTHJun 29 · 23:00 UTCPENNSYLVANIA CAPITAL-STAR
    Pa. joins multi-state lawsuit against Trump administration over Medicaid work requirement rules

    Pennsylvania has joined a multi-state lawsuit challenging the Trump administration's Medicaid work requirement rules under the One Big Beautiful Bill Act. The lawsuit argues the new requirements, which mandate community engagement and work hours for Medicaid benefits, will cause harm and complexity for states to implement.

  • HEALTHJun 29 · 21:14 UTCFLORIDA PHOENIX
    Federal health agency cancels most of its teen pregnancy prevention grants

    The U.S. Health and Human Services agency canceled 53 out of 67 grants under the Teen Pregnancy Prevention Program, affecting $68 million in funding for organizations in over two dozen states. The cancellations, effective immediately, were cited as misaligned with agency priorities, particularly for programs deemed to normalize or promote sexual activity for minors.

  • HEALTHJun 29 · 14:00 UTCARIZONA MIRROR
    Federal health agency cancels most of its teen pregnancy prevention grants

    The U.S. Health and Human Services agency canceled 53 out of 67 grants under its Teen Pregnancy Prevention Program, affecting over $68 million in funding across multiple states. The termination cited misalignment with agency priorities, including claims that some programs 'normalize or promote sexual activity for minors.'

  • HEALTHJun 29 · 07:45 UTCWISCONSIN EXAMINER
    Federal health agency cancels most of its teen pregnancy prevention grants

    The U.S. Health and Human Services agency canceled 53 out of 67 grants under the Teen Pregnancy Prevention Program, affecting over $68 million in funding across more than two dozen states. The cancellations, effective immediately, were cited as misaligned with agency priorities, particularly for programs deemed to 'normalize or promote sexual activity for minors.'

  • HEALTHJun 27 · 14:20 UTCPENNSYLVANIA CAPITAL-STAR
    Federal health agency cancels most of its teen pregnancy prevention grants, including some in Pa.

    The U.S. Health and Human Services agency canceled 53 out of 67 grants under its Teen Pregnancy Prevention Program, citing misalignment with agency priorities, including those funding programs in Pennsylvania. The cancellations, effective immediately, affect $68 million in funding for organizations like AccessMatters, which provides reproductive health services to over 1,100 teens. The Trump administration previously took similar actions in 2017, leading to a lawsuit.

  • HEALTHJun 27 · 10:00 UTCLOUISIANA ILLUMINATOR
    Federal health agency cancels most of its teen pregnancy prevention grants

    The U.S. Health and Human Services agency canceled 53 out of 67 grants under its Teen Pregnancy Prevention Program, affecting $68 million in funding across multiple states. Grantees, including universities and Planned Parenthood affiliates, were notified the programs misaligned with agency priorities, such as normalizing sexual activity for minors.

  • HEALTHJun 26 · 22:29 UTCMICHIGAN ADVANCE
    Federal health agency cancels most of its teen pregnancy prevention grants, including in Michigan

    The U.S. Health and Human Services agency canceled 53 out of 67 Teen Pregnancy Prevention Program grants, affecting over $68 million in funding across multiple states including Michigan. The termination cited misalignment with agency priorities, including claims that some programs 'normalize or promote sexual activity for minors.'

  • HEALTHJun 22 · 18:27 UTCMISSOURI INDEPENDENT
    Family planning organizations sue Trump administration over Title X funding announcement

    The National Family Planning and Reproductive Health Association and a Pennsylvania family planning organization sued the U.S. Health and Human Services agency, alleging politicization of the Title X grant program through the 2027 Notice of Funding Opportunity. The complaint claims the new funding priorities conflict with the law's intent by requiring applicants to align with policies ending diversity efforts and gender-affirming care.

  • HEALTHJun 22 · 07:05 UTCOHIO CAPITAL JOURNAL
    Family planning organizations sue Trump administration over Title X funding announcement

    The National Family Planning and Reproductive Health Association and the Family Health Council of Central Pennsylvania sued the U.S. Health and Human Services agency over changes to Title X funding rules. The lawsuit alleges the Trump administration is politicizing the Title X program by requiring applicants to align with priorities like ending diversity initiatives and gender-affirming care, which conflict with the program's original intent. The case is assigned to U.S. District Judge Yvette Kane.

  • HEALTHJun 18 · 23:54 UTCMICHIGAN ADVANCE
    Family planning organizations sue Trump administration over Title X funding announcement

    The National Family Planning and Reproductive Health Association and a Pennsylvania-based family planning organization sued the U.S. Health and Human Services agency, alleging that the Title X grant program is being politicized. The lawsuit challenges the 2027 funding priorities, which include ending diversity, equity, and inclusion efforts and gender-affirming care, as conflicting with the program's intended purpose.

  • HEALTHJun 17 · 21:52 UTCKOAA NBC5 COLORADO SPRINGS
    U.S. FDA, HHS, GSA break ground on $228M food lab at the Denver Federal Center

    The U.S. FDA, HHS, and GSA broke ground on a $228 million food lab at the Denver Federal Center to enhance research capabilities for managing foodborne illness outbreaks and ensuring safety. The facility will be the FDA's only Biosafety Level 3 lab west of the Mississippi River, replacing outdated infrastructure and expected to open by 2029.

  • HEALTHJun 17 · 16:35 UTCKMGH DENVER7
    U.S. FDA, HHS, GSA break ground on $228M food lab at the Denver Federal Center

    The U.S. FDA, HHS, and GSA broke ground on a $228 million food lab at the Denver Federal Center to enhance food safety research and replace outdated facilities. The lab will be the FDA's only Biosafety Level 3 facility west of the Mississippi River, aiming to improve responses to foodborne illness outbreaks and ensure product safety.

  • HEALTHMay 14 · 18:48 UTCTHE HILL
    Hospital says RFK Jr. did not operate robotic arm during heart surgery

    The Cleveland Clinic denied a report that Robert F. Kennedy Jr., the US Health and Human Services Secretary, operated a robotic arm during heart surgery. He was merely an observer of the procedure as part of a broader tour. The clinic clarified his role to correct the initial report.

  • HEALTHMay 5 · 18:05 UTCTHE HILL
    RFK Jr. unveils campaign for ‘deprescribing’ antidepressants

    US Health and Human Services Secretary Robert F. Kennedy Jr. announced a new initiative to reduce the use of psychiatric medications, especially antidepressants. The initiative aims to address the nation's mental health crisis by 'deprescribing' these medications. This effort is part of the Make America Healthy Again Institute summit.

  • HEALTHMay 5 · 13:12 UTCSTAT NEWS
    STAT+: Pharmalittle: We’re reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more

    US Health and Human Services Secretary Robert F. Kennedy Jr. has announced initiatives to reduce the prescription of selective serotonin reuptake inhibitors, a class of antidepressants. Johnson & Johnson is advancing a therapy for inflammatory bowel disease into late-stage testing despite initial results not showing statistically meaningful improvement. The initiatives aim to help patients get off medications and consider non-pharmaceutical interventions.

US Health and Human Services · Dossier · The Nexus